How antibacterials really work: Impact on drug discovery

Future Microbiology

Volumn 6, Issue 6, 2011, Pages 603-604

  Dick, Thomas ^b   Young, Douglas ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

Author keywords

antibacterials; drug induced bacterial cell death; tuberculosis

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BACTERIAL ENZYME; BETA LACTAM; CHLORAMPHENICOL; QUINOLONE DERIVATIVE; TETRACYCLINE;

ANTIBACTERIAL ACTIVITY; BACTERIAL CELL; CELL DEATH; DNA SYNTHESIS; DRUG DEVELOPMENT; EDITORIAL; GENOME; HOMEOSTASIS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN SYNTHESIS; RNA SYNTHESIS;

ANTI-BACTERIAL AGENTS; DRUG DISCOVERY; HUMANS;

BACTERIA (MICROORGANISMS);

EID: 79959781700     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.11.26     Document Type: Editorial

References (14)

1. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ: A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130, 797-810 (2007 (Pubitemid 47332566)
2. Dwyer DJ, Kohanski MA, Hayete B, Colins JJ: Gyrase inhibitors induce an oxidative damage cellular death pathway in Escherichia coli. Mol. Syst. Biol. 3, 1-15 (2007
3. Kohanski MA, Dwyer DJ, Wierzbowski J, Cottarel G, Collins JJ: Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death. Cell 135, 679-690 (2008
4. Drlica K, Malik M, Kerns RJ, Zhao X: Quinolone-mediated bacterial death. Antimicrob. Agents Chemother. 52, 385-392 (2008 (Pubitemid 351170804)
5. Van Stelten J, Silva F, Belin D, Silhavy TJ: Effects of antibiotics and a proto-oncogene homolog on destruction of protein translocator SecY. Science 325, 753-756 (2009
6. Kohanski MA, Dwyer DJ, Collins JJ: How antibiotics kill bacteria. Nat. Rev. Microbiol. 8, 423-435 (2010
7. Kalscheuer R, Syson K, Veeraraghavan U et al.: Self-poisoning of Mycobacterium tuberculosis by targeting GlgE in an a-glucan pathway. Nat. Chem. Biol. 6, 376-384 (2010
8. Pethe K, Sequeira P, Agarwalla S et al.: A chemical genetic screen in M. tuberculosis identifies carbon-source dependent growth inhibitors devoid of in vivo efficacy. Nat. Commun. 1, 57 (2010
9. Sala C, Dhar N, Hartkorn RC et al.: Simple model for testing drugs against nonreplicating Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 54, 4150-4158 (2010
10. Lounis N, Gevers T, Van den Berg J, Vranckx L, Andries K: ATP synthase inhibition of Mycobacterium avium is not bactericidal. Antimicrob. Agents Chemother. 53, 4927-4929 (2009
11. Payne DJ, Gwynn MN, Holmes DJ, Pompliano DL: Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat. Rev. Drug Discov. 6, 29-40 (2007 (Pubitemid 46020284)
12. Barry CE, Boshoff H, Dartois V et al.: The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7, 845-855 (2009
13. Dartois V, Leong FJ, Dick T: Tuberculosis drug discovery: issues, gaps and the way forward. In: Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates. Selzer PM (Ed.Wiley- VCH, Weinheim, Germany, 415-440 (2009
14. Interlandi J: Are we running out of antibiotics? Newsweek CLVI 36-41, December (2010).